Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Weinstein

Showing results (201-210 of 611) with videos related to

Pageof 62
Sort By:
International Journal of Technology Assessment in Health Care|January 1, 1990
Cost-effectiveness study of the extracorporeal shock-wave lithotriptorE E Hatziandreu, K Carlson, A G Mulley, et al.
AIDS (London, England)|January 11, 2000
The cost-effectiveness of elective Cesarean delivery for HIV-infected women with detectable HIV RNA during pregnancyJ M Mrus, S J Goldie, M C Weinstein, et al.
Medical Care|April 17, 1998
Heterogeneity in the relationship between the time tradeoff and Short Form-36 for HIV-infected and primary care patientsJ R Bult, M G Hunink, J Tsevat, et al.
Plos Medicine|June 27, 2006
Cost-effectiveness of treating multidrug-resistant tuberculosisStephen C Resch, Joshua A Salomon, Megan Murray, et al.
American Journal of Perinatology|January 1, 1984
Management of pregnancy subsequent to rupture of an intracranial arterial aneurysmV A Catanzarite, J E Ferguson, P Hensleigh, et al.
Plos Medicine|November 16, 2006
Packaging health services when resources are limited: the example of a cervical cancer screening visitJane J Kim, Joshua A Salomon, Milton C Weinstein, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|September 16, 2004
Cost-effectiveness of interferon beta-1a, interferon beta-1b, and glatiramer acetate in newly diagnosed non-primary progressive multiple sclerosisLisa A Prosser, Karen M Kuntz, Amit Bar-Or, et al.
Annals of Internal Medicine|March 6, 1999
The costs, clinical benefits, and cost-effectiveness of screening for cervical cancer in HIV-infected womenS J Goldie, M C Weinstein, K M Kuntz, et al.
JAMA|October 23, 1996
Recommendations for reporting cost-effectiveness analyses. Panel on Cost-Effectiveness in Health and MedicineJ E Siegel, M C Weinstein, L B Russell, et al.
Journal of the American Society of Nephrology : JASN|October 1, 1992
Cost-effectiveness of screening and early treatment of nephropathy in patients with insulin-dependent diabetes mellitusJ E Siegel, A S Krolewski, J H Warram, et al.
Pageof 62

Showing results (201-210 of 611) with videos related to

Sort By:
Pageof 62
International Journal of Technology Assessment in Health Care|January 1, 1990
Cost-effectiveness study of the extracorporeal shock-wave lithotriptorE E Hatziandreu, K Carlson, A G Mulley, et al.
AIDS (London, England)|January 11, 2000
The cost-effectiveness of elective Cesarean delivery for HIV-infected women with detectable HIV RNA during pregnancyJ M Mrus, S J Goldie, M C Weinstein, et al.
Medical Care|April 17, 1998
Heterogeneity in the relationship between the time tradeoff and Short Form-36 for HIV-infected and primary care patientsJ R Bult, M G Hunink, J Tsevat, et al.
Plos Medicine|June 27, 2006
Cost-effectiveness of treating multidrug-resistant tuberculosisStephen C Resch, Joshua A Salomon, Megan Murray, et al.
American Journal of Perinatology|January 1, 1984
Management of pregnancy subsequent to rupture of an intracranial arterial aneurysmV A Catanzarite, J E Ferguson, P Hensleigh, et al.
Plos Medicine|November 16, 2006
Packaging health services when resources are limited: the example of a cervical cancer screening visitJane J Kim, Joshua A Salomon, Milton C Weinstein, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|September 16, 2004
Cost-effectiveness of interferon beta-1a, interferon beta-1b, and glatiramer acetate in newly diagnosed non-primary progressive multiple sclerosisLisa A Prosser, Karen M Kuntz, Amit Bar-Or, et al.
Annals of Internal Medicine|March 6, 1999
The costs, clinical benefits, and cost-effectiveness of screening for cervical cancer in HIV-infected womenS J Goldie, M C Weinstein, K M Kuntz, et al.
JAMA|October 23, 1996
Recommendations for reporting cost-effectiveness analyses. Panel on Cost-Effectiveness in Health and MedicineJ E Siegel, M C Weinstein, L B Russell, et al.
Journal of the American Society of Nephrology : JASN|October 1, 1992
Cost-effectiveness of screening and early treatment of nephropathy in patients with insulin-dependent diabetes mellitusJ E Siegel, A S Krolewski, J H Warram, et al.
Pageof 62